2BB score and signals
Acrivon Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 32 | Low |
| Momentum | 67 | Improving |
| Financial strength | 19 | Very Weak |
| Quality | 71 | Strong |
| Risk | 62 | High |
Company facts
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2018 |
| Employees | 75 |
| 52-week range | $1.27 – $3.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-17 | — | -0.4434 | — | $0.00 |
| 2026-11-11 | — | -0.453 | — | $0.00 |
| 2026-08-19 | — | -0.51 | — | $0.00 |
| 2026-05-13 | -0.49 | -0.5359 | $0.00 | $282,203.00 |
Related companies
